ADACEL-POLIO
ADACEL-POLIO
Approved
DIN Number
02352044
Drug Class
Human
Market Date
Mar 11, 2011
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02352044
AIG Number0965263002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07CA02 DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (9)
DIPHTHERIA TOXOIDActive
Strength: 2 LF / 0.5 ML
Monograph: DIPHTHERIA TOXOID
FILAMENTOUS HAEMAGGLUTININActive
Strength: 5 MCG / 0.5 ML
Monograph: FILAMENTOUS HAEMAGGLUTININ
FIMBRIAE TYPES 2 AND 3 (FIM)Active
Strength: 5 MCG / 0.5 ML
Monograph: FIMBRIAE TYPES 2 AND 3 (FIM)
PERTACTINActive
Strength: 3 MCG / 0.5 ML
Monograph: PERTACTIN
PERTUSSIS TOXOIDActive
Strength: 2.5 MCG / 0.5 ML
Monograph: PERTUSSIS TOXOID
POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED)Active
Strength: 29 UNIT / 0.5 ML
Monograph: POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED)
POLIOVIRUS TYPE 2 MEF1 (INACTIVATED)Active
Strength: 7 UNIT / 0.5 ML
Monograph: POLIOVIRUS TYPE 2 MEF1 (INACTIVATED)
POLIOVIRUS TYPE 3 SAUKETT (INACTIVATED)Active
Strength: 26 UNIT / 0.5 ML
Monograph: POLIOVIRUS TYPE 3 SAUKETT (INACTIVATED)
TETANUS TOXOIDActive
Strength: 5 LF / 0.5 ML
Monograph: TETANUS TOXOID